Updated as of November 19, 2026
“A New Path Forward”
“SPRAVATO® (esketamine) is an FDA-approved treatment for adults with treatment-resistant depression and certain severe depressive episodes. Offered in a calm, pr…”
Resolute introduces Spravato as a treatment for adults with treatment-resistant depression and certain severe depressive episodes. Its A New Path Forward headline offers hope, while Contact us gives interested people a direct response option.
Copy this: Use a hopeful headline, then specify who the treatment is intended for.